Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Similar documents
CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

Current and Future Imaging Trends in Risk Stratification for CAD

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

New Technologies for Cardiac CT. Geoffrey D. Rubin, MD, MBA, FACR, FNASCI Duke University

Diagnostic and Prognostic Value of Coronary Ca Score

CT or PET/CT for coronary artery disease

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Cardiac CT Angiography

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

I have no financial disclosures

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Is computed tomography angiography really useful in. of coronary artery disease?

The Emerging Role of Cardiac CT in Cardiovascular Imaging. Anthony Gemignani, MD Vermont Cardiac Network April 28, 2016

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

CARDIAC IMAGING FOR SUBCLINICAL CAD

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Stress only Perfusion Imaging

Multidetector CT Angiography for the Detection of Left Main Coronary Artery Disease. Rani K. Hasan, M.D. Intro to Clinical Research July 22 nd, 2011

MD F A F C A C MAS A N S C

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Physiologic Assessment by Cardiac CT

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Computed tomography in coronary imaging: current status

Intervention: How and to which extent is technology helping us?

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

Disclosure Information

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose

CT Coronary Angiography - Indications: From the guidelines to clinical practice

FFR-CT Not Ready for Primetime

Cover Page. The handle holds various files of this Leiden University dissertation

How to investigate (Cardiac) Chest Pain

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

MEDICAL UNIVERSITY of SOUTH CAROLINA

Patient referral for elective coronary angiography: challenging the current strategy

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Diabetes and Occult Coronary Artery Disease

Calcium scoring Clinical and prognostic value

Chest pain. One problem different approaches... Question 1 what is your choice? In-/Exclusion Criteria

State-of-the-Art SPECT/CT: Cardiac Imaging

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

The invisible becomes quantifiable in coronary computed tomography angiography exams with CT-FFR

Test in Subjects with Suspected CAD Anatomic Study is Better

Review Article A New Approach in Risk Stratification by Coronary CT Angiography

Malaysian Healthy Ageing Society

SPECT CT Current Status and Future Direction Nuclear Cardiology

. θωρακικούάλγουςστα εξωτερικά ιατρεία

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Potential recommendations for CT coronary angiography in athletes

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

CASE from South Korea

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

CARDIOLOGY GRAND ROUNDS

Diagnostic Algorithms

Welcome! To submit questions during the presentation: or Text:

Pearls & Pitfalls in nuclear cardiology

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Fellows on this rotation are expected to attend nuclear conferences and multimodality imaging conference.

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Ultrasound. Computed tomography. Case studies. Utility of IQon Spectral CT in. cardiac imaging

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

New Insight about FFR and IVUS MLA

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Contrast-Enhanced Computed Tomography Angiography for Coronary Artery Evaluation

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Recent Advances in Nuclear Cardiology, Cardiac CT, and Cardiac MRI: Applications for CAD in the Era of Value-based Imaging

Imaging of the Heart Todd Tessendorf MD FACC

CARDIAC MULTIMODALITY IMAGING: Informing better decisions - or just costly pictures?

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach

CT-based myocardial ischemia evaluation: quantitative angiography, myocardial perfusion, and CT-FFR

Characteristics of Subclinical Coronary Artery Disease in Diabetic Patients without Known Coronary Artery Disease

Cardiac Computed Tomography

Risk Stratification for CAD for the Primary Care Provider

Horizon Scanning Technology Summary. Magnetic resonance angiography (MRA) imaging for the detection of coronary artery disease

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Myocardial Perfusion: Positron Emission Tomography

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Adapted Transfer Function Design for Coronary Artery Evaluation

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Correlation of Cardiac CTA to Conventional Cardiac Angiography in Diagnosing Coronary Artery Stenosis in a Community Based Center

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Cardiac CT: Your chest pain patient CAN be discharged from the Emergency Department

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Medical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Transcription:

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

No conflict of interest to disclose

Noninvasive Cardiac Imaging Unresolved Issues-Future Directions Risk stratification in symptomatic and asymptomatic patients Algorithms-Appropriateness criteria-clinical management-cost-effectiveness in the multimodality era Proper combination of anatomy and function data Predicting vulnerable plaques-vulnerable patients Issues of training-accreditation-medical specialties interactions

CONFIRM

AIM-METHODS -Examines the prognostic significance of CCTA -24775 pts without known CAD (with typical or atypical chest pain), CCTA in 64 slice scanners. CAD severity was judged on a per patient, per vessel and per segment basis as follows: None (0%) Mild (0-49%) Moderate (50-69%) Severe (>70%) Pts were followed up for 2.3 years and time to death was primary end-point

Pts without any CAD had annualized death rate 0,28%, >4 years FU 0,22%

-Presence of any and extend of CAD assessed cy CCTA carries prognostic information -Absence of any CAD is related to very low risk of death -Pre-test likelihood of obstructive CAD was predictive of the presence of obstructive CAD but not of DEATH -Open label study-registry, effects to management have not been studied

Promise Trial CCTA fewer ICA showing no obstructive CAD (3,4% vs 4,3%, P=0,02) CCTA lower median cumulative radiation exposure (10 vs 11,3mSv)

-Reduction of ICAs with normal findings -Increase of preventive therapies -Increase in revascularization

CTA IN ACUTE CHEST PAIN - High negative predictive power - CT-STAT, AGRIN-PA, ROMICAT II, CT COMPARE and CATCH trials have shown significant reductions in length of stay, costs and safe discharge in low to intermediate risk pts - Increase in ICA and revascularizations -Triple rule out protocols

CTA IN ACUTE CHEST PAIN

Better long term prognosis

CTA IN ACUTE CHEST PAIN Guidelines

ACS proposed Algorithm

CTA IN ACUTE CHEST PAIN

All these data and the pathophysiology of CAD emphasize the need for combined anatomyfunction approaches, the most promising one being CTA derived FFR

FFR-CT Three principles: -Coronary supply meets myocardial demand at rest (ACS EXCLUDED) Total resting blood flow can be calculated relative to LV mass -Resistance of the microcirculation is inversely but not linearly proportional to the sixe of the epicardial vessel -Microcirculation reacts predictably to maximal hyperemic conditions In pts with normal coronary flow

DEFACTO Trial

CTA-FFR PLATFORM Trial

CT Perfusion Static or dynamic Single or dual energy

CT perfusion

TAG (Transluminal Attenuation Gradient)

CTA-FUNCTIONAL DATA

MSCT Assessment of coronary plaques Achenbach S.EHJ 2010;31;1442

MSCT Rationale -Detection of CAD at an earlier stage than functional imaging -Allows shift from stenosis to atherosclerosis imaging -Differentiation of mild coronary atheromatosis to normal coronaries (1,5% vs 0,7% annual event rates) -Ability to visualize vessel wall -Plaque burden-location -Plaque remodeling and composition Van Werkhoven J. J Nuclear Cardiology 2009;16: 970

MSCT -An increase in plaque burden is associated with increased risk for vulnerable plaques -Number of segments diseased, location and severity are associated with risk Van Werkhoven J. J Nuclear Cardiology 2009;16: 970

MSCT Plaque remodeling and composition - Several studies have shown that pts with ACS have more outward remodeling, noncalcified or mixed plaques (independent risk predictor) -No plaques 0 events -Atherosclerosis no high risk feature (0,49% event rate) -1 high risk feature (3,7% event rate) -2 high risk features (22,2% event rate) Van Werkhoven J. J Nuclear Cardiology 2009;16: 970

-No plaques 0 events -Atherosclerosis no high risk feature (0,49% event rate) -1 high risk feature (3,7% event rate) -2 high risk features (22,2% event rate)

MSCT-PLAQUE CHARACTERIZATION Differentiation Between Stable and Unstable Coronary Artery Culprit Plaques by 64-Slice CT Coronary Angiography Meijs MFL, Meijboom B, Cramer MJ, Kyrzopoulos S, Neoh, Prokop M, Doevendans PA, de Feyter PJ Am J Cardiol. 2009 104(3):305-11. Compared to SA patients, UA patients had larger plaques and more non-calcified plaques and less calcified plaques. In addition to the measurement of stenosis degree, CTCA may improve individual risk estimation by identifying plaque type and relative plaque CSA.

MSCT Limitations -Accuracy (compared to ivus) 95% and 94% for calcified and mixed plaques, but only 83% for noncalcified lesions -Significant overlap in attenuation values -Regarding plaque volume MSCT overestimates calcific plaques, and underestimates noncalcified and mixed plaques Van Werkhoven J. J Nuclear Cardiology 2009;16: 970

Novel Applications High definition CT scanner (in plane resolution of 0,23mm) Iterative reconstruction High pitch CT Dual source CT Second generation 320-detector row scanners Motion correction algorithms

Conclusions Future directions of non-invasive cardiac imaging will most likely involve: Improved risk stratification in symptomatic and asymptomatic patients Algorithms-Appropriateness criteria-clinical management-cost-effectiveness in the multimodality era Proper combination of anatomy and function data Predicting vulnerable plaques-vulnerable patients Issues of training-accreditation-medical specialties interactions